All BioXcellence articles

News

Boehringer Ingelheim signs gene therapy manufacturing deal with AnGes

2025-08-20T11:42:57Z

The German pharma company’s BioXcellence arm will supply the drug substance for AnGes’ peripheral arterial disease treatment Collategene.